Epstein Secrets

sit ea...dried Quell Dbatausilrb mirk. art the trademark% orciaral PAGE I OF I EFTA00314225 411)()uest °tannest ts —• Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY 110B: AGE: 65 t ;ender: M MIMI:: Patient ID: I lealt

TA00314235 Surgery Office Clinic Note Epstein, Jeffrey E - Final Report * * Final Report * Referring Phy

MD (Electronically Signed) Contrtbuling ProvIdor(c): 1) Melba, Sherif I 2) KESTENBAUM, DAVID EFTA00314235 Surgery Office Clinic Note Epstein, Jeffrey E - Final Report * * Final Report * Referring Physician Dr. Bruce Moskowitz fridocrinolggist None Chief Complaint Primary Hyperparathyroidism Hist

cc Creatinine 1.2mgkii REPORT CC: CC PATIENT EPSTEIN JEFFREY ACCT Exam Date: 1/30118 DOB: EAST RIVER MEDICAL

Hyperparathyroidism History of Present Illness Mr. Epstein, Jeffrey is a 65-year-old male who presents for s

/dL for primary prevention; <70 mg/dL for patients with CHD or diabetic patients with > or • 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Mar ' • • 2 1

5 EFTA00304870 rajQuest Diagnostics' -00 Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR047985L Collected: 08/14/2018 R

uest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Clien

/dL for primary prevention; <70 mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al

rajQuest Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Specimen: MR495703L Requisition: 0006136 Gender:

st Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information EPSTE

/dL for primary prevention; <70 mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al

libj Quest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Phone: Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name LIPID PANEL, STANDARD CHOLE

uest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Clien

/dL for primary prevention; <70 mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al

(0)Quest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Phone: 561.366.0084 Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR8391 ION Re

uest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Clien

/dL for primary prevention; <70 mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al

raj Quest —40 Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Phone: 561.366.0084

—40 Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Clien

/dL for primary prevention; <70 mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al

abj Quest Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Phone: 561.366.0084

st Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Clien

/dL for primary prevention; <70 mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al

EFTA00304997 60) Quest Diagnostics' —.• Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 64 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR156329E Collected: 01/05/2018 R

uest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Chent

range <100 mg/dL for patients with CHD or diabetes and <70 mg/dL for diabetic patients with known heart disease. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al